Dr. Kornbrust earned a Ph.D. in Toxicology from the University of Rochester and received additional training as a postdoctoral fellow at the Chemical Industry Institute of Toxicology at Research Triangle Park, NC. Dr. Kornbrust’s experience in the planning and management of nonclinical portions of drug development programs, interactions with regulatory agencies and assistance with regulatory filings is extensive and includes consultancy relationships with more than 170 pharmaceutical companies since 2002. Dr. Kornbrust was formerly Vice President and Scientific Director for Sierra Biomedical (now Charles River Laboratories Nevada) and Director of Toxicology, Pharmacokinetics and Metabolism at ISIS Pharmaceuticals, a leader in the development of oligonucleotide-based medicines.
Dr. Roggendorf earned his M.D. from the University of Bonn Medical School. He currently is a visiting Professor at the Institute for Virology, Technical University of Munich and serves on the Advisory Boards for the German Network of Competence for Hepatitis (Hep-Net) and the SFB / German – Chinese Transregio (SFB/TRR60) and was previously Director of the Institute of Virology, University of Duisburg – Essen and Head of the Diagnostic Laboratory of Viral Diseases and Hepatitis Research at the University of Munich. Dr. Roggendorf has authored more than 370 publications in the areas of virology and viral hepatitis. Recently he published several studies on immunomodulatory therapies in chronic hepatitis B. He is an expert reviewer for national and international research agencies, including the National Institutes of Health (USA).
Dr. Trepo graduated from the School of Medicine and Sciences of Lyon and Grenoble while completing Fogarty International Center fellowships in Virology at the New York Blood Center and in Hepatology at Cornell University Medical College (NY, USA). Dr. Trepo is currently an Emeritus Professor at Claude Bernard University and a consultant at the Hepatogastroenterology department at Croix Rousse Hospital and acting Director of the Hepatitis Unit (INSERM 1052/CRCL), in Lyon, France. He has previously served in several important positions, including the Advisory Board for the European Association for the Study of the Liver, President of the French Association for the Study of the Liver, Medical Coordinator of the Hepatitis C reference Center. He has also been a consultant for several government agencies and pharmaceutical companies. Dr. Trepo has authored more than 750 articles in the areas of virology and viral hepatitis including hepatitis delta virus (HDV) from its initial finding, where he co-authored the milestone HDV discovery paper.